Trial primary completion date • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor) • BRCA1 (Breast cancer 1, early onset) • IFNG (Interferon, gamma) • IL17A (Interleukin 17A) • PRL (Prolactin)
|
BRCA1 mutation • HER-2 negative • PALB2 mutation • ER negative • PGR negative
|
alpha-lactalbumin vaccine